Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.

D'Angelo S, Tirri E, Giardino AM, Mattucci-Cerinic M, Dagna L, Santo L, Ciccia F, Frediani B, Govoni M, Bobbio Pallavicini F, Grembiale RD, Delle Sedie A, Mulè R, Cantatore FP, Foti R, Gremese E, Conigliaro P, Salaffi F, Viapiana O, Cauli A, Giacomelli R, Arcarese L, Guggino G, Russo R, Puenpatom A, Capocotta D, Nacci F, Anelli MG, Picerno V, Binetti C, Iannone F

Open source

DOI: 10.3390/jcm11144178
Published: 2022 Jul 19
Container: Journal of clinical medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/jcm11144178,
  title = {Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.},
  author = {D'Angelo S and Tirri E and Giardino AM and Mattucci-Cerinic M and Dagna L and Santo L and Ciccia F and Frediani B and Govoni M and Bobbio Pallavicini F and Grembiale RD and Delle Sedie A and Mulè R and Cantatore FP and Foti R and Gremese E and Conigliaro P and Salaffi F and Viapiana O and Cauli A and Giacomelli R and Arcarese L and Guggino G and Russo R and Puenpatom A and Capocotta D and Nacci F and Anelli MG and Picerno V and Binetti C and Iannone F},
  year = {2022},
  journal = {Journal of clinical medicine},
  doi = {10.3390/jcm11144178},
  url = {https://doi.org/10.3390/jcm11144178}
}

RIS

TY  - JOUR
TI  - Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.
AU  - D'Angelo S
AU  - Tirri E
AU  - Giardino AM
AU  - Mattucci-Cerinic M
AU  - Dagna L
AU  - Santo L
AU  - Ciccia F
AU  - Frediani B
AU  - Govoni M
AU  - Bobbio Pallavicini F
AU  - Grembiale RD
AU  - Delle Sedie A
AU  - Mulè R
AU  - Cantatore FP
AU  - Foti R
AU  - Gremese E
AU  - Conigliaro P
AU  - Salaffi F
AU  - Viapiana O
AU  - Cauli A
AU  - Giacomelli R
AU  - Arcarese L
AU  - Guggino G
AU  - Russo R
AU  - Puenpatom A
AU  - Capocotta D
AU  - Nacci F
AU  - Anelli MG
AU  - Picerno V
AU  - Binetti C
AU  - Iannone F
PY  - 2022
JO  - Journal of clinical medicine
DO  - 10.3390/jcm11144178
UR  - https://doi.org/10.3390/jcm11144178
ER  -

APA

S, D., E, T., AM, G., M, M., L, D., L, S., F, C., B, F., M, G., F, B. P., RD, G., A, D. S., R, M., FP, C., R, F., E, G., P, C., F, S., O, V., A, C., R, G., L, A., G, G., R, R., A, P., D, C., F, N., MG, A., V, P., C, B., & F, I. (2022). Effectiveness of Golimumab as Second Anti-TNFα Drug in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Axial Spondyloarthritis in Italy: GO-BEYOND, a Prospective Real-World Observational Study.. Journal of clinical medicine. https://doi.org/10.3390/jcm11144178

Source records

pubmed · retrieved 2026-09-26T04:38:07.856Z